Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: A population-based epidemiological study

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Ley, Sylvia H ^a   Hegele, Robert A ^b   Connelly, Philip W ^c,d   Harris, Stewart B ^e   Mamakeesick, Mary ^f   Cao, Henian ^b   Gittelsohn, Joel ^g   Retnakaran, Ravi ^a,h   Zinman, Bernard ^a,h   Hanley, Anthony J ^a,h  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e WESTERN UNIVERSITY   (Canada)

^f Sandy Lake Health and Diabetes Project   (Canada)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; TRIACYLGLYCEROL; HNF1A PROTEIN, HUMAN;

ABORIGINE; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANADA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION; ADOLESCENT; AMERICAN INDIAN; CARDIOVASCULAR DISEASE; CHILD; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CANADA; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; INDIANS, NORTH AMERICAN; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77955652045     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-39     Document Type: Article

References (30)

1. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350(14):1387-1397. 10.1056/NEJMoa032804, 15070788.
2. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med 2008, 264(4):295-314. 10.1111/j.1365-2796.2008.02015.x, 18823504.
3. Reiner AP, Barber MJ, Guan Y, Ridker PM, Lange LA, Chasman Daniel I, Walston JD, Cooper GM, Jenny NS, Rieder MJ, et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008, 82(5):1193-1201. 10.1016/j.ajhg.2008.03.017, 2427318, 18439552.
4. Ridker PM, Pare G, Parker A, Zee RYL, Danik JS, Buring JE, Kwiatkowski D, Cook NR, Miletich JP, Chasman DI. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008, 82(5):1185-1192. 10.1016/j.ajhg.2008.03.015, 2427311, 18439548.
5. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302(1):37-48. 10.1001/jama.2009.954, 2803020, 19567438.
6. Ryffel G. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 2001, 27(1):11-29. 10.1677/jme.0.0270011, 11463573.
7. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001, 345(13):971-980. 10.1056/NEJMra002168, 11575290.
8. Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006, 27(9):854-869. 10.1002/humu.20357, 16917892.
9. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384(6608):455-458. 10.1038/384455a0, 8945470.
10. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki P, Boriraj V, Chevre J, Boccio V, Cox R, Lathrop G, et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 1997, 6(4):583-586. 10.1093/hmg/6.4.583, 9097962.
11. Hegele RA, Cao H, Harris SB, Hanley AJG, Zinman B. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 1999, 84(3):1077-1082. 10.1210/jc.84.3.1077, 10084598.
12. Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K, Hanley AJ, Zinman B, Harris SB, Barrett PH, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc Natl Acad Sci USA 2002, 99(7):4614-4619. 10.1073/pnas.062059799, 123696, 11904371.
13. Harris S, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care 1997, 20(2):185-187. 10.2337/diacare.20.2.185, 9118771.
14. Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord 2003, 27(3):347-354. 10.1038/sj.ijo.0802239, 12629562.
15. Lipid Research Clinics Program Manual of Laboratory Operations. 1984, 1-81. Washington D, U.S. Govt. Printing Office, (NIH publ. no. 75-6282), Lipid Research Clinics Program.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
17. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511. 10.1161/01.CIR.0000052939.59093.45, 12551878.
18. Liu S, Tinker L, Song Y, Rifai N, Bonds DE, Cook NR, Heiss G, Howard BV, Hotamisligil GS, Hu FB, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007, 167(15):1676-1685. 10.1001/archinte.167.15.1676, 17698692.
19. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286(3):327-334. 10.1001/jama.286.3.327, 11466099.
20. Krakoff J, Funahashi T, Stehouwer CDA, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003, 26(6):1745-1751. 10.2337/diacare.26.6.1745, 12766104.
21. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2003, 52(7):1799-1805. 10.2337/diabetes.52.7.1799, 12829649.
22. Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Hegele RA, Retnakaran R, Zinman B, Hanley AJ. Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care 2008, 31(7):1410-1415. 10.2337/dc08-0036, 2453664, 18339973.
23. Toniatti C, Demartis A, Monaci P, Nicosia A, Ciliberto G. Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J 1990, 9(13):4467-4475. 552239, 2265613.
24. Li S-P, Goldman ND. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry 1996, 35(28):9060-9068. 10.1021/bi953033d, 8703909.
25. Nishikawa T, Hagihara K, Serada S, Isobe T, Matsumura A, Song J, Tanaka T, Kawase I, Naka T, Yoshizaki K. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol 2008, 180(5):3492-3501.
26. Harries LW, Sloman MJ, Sellers EAC, Hattersley AT, Ellard S. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts. Diabetes 2008, 57(7):1978-1982. 10.2337/db07-1633, 2453634, 18586913.
27. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005, 115(5):1111-1119. 1087185, 15864338.
28. Taghavi S, Fatemi S, Rafatpanah H, Ganjali R, Tavakolafshari J, Valizadeh N. Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young. Cardiovasc Diabetol 2009, 8(1):63. 10.1186/1475-2840-8-63, 2797770, 20003313.
29. Giuffrida F, Furuzawa G, Kasamatsu T, Oliveira M, Reis A, Dib S. HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study. Cardiovas Diabetol 2009, 8(1):28.
30. Lehman DM, Richardson DK, Jenkinson CP, Hunt KJ, Dyer TD, Leach RJ, Arya R, Abboud HE, Blangero J, Duggirala R, et al. P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans. Diabetes 2007, 56(2):513-517. 10.2337/db06-0881, 17259399.